Association between  ADIPOQ  rs2241766 polymorphism and risk of diabetic nephropathy

Hanyu Zhu; Dong Zhang; Wenjia Geng; Ying Zheng; Jie Wu; Zheyi Dong; Weiguang Zhang; Fenglin Xiao; Moyan Liu; Zuoxiang Li; Shuwei Duan; Guangyan Cai; Xiangmei Chen

doi:10.18632/oncotarget.19834

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Withdrawal Notice

This paper was originally published in Oncotarget Advance Online Publications on 08/03/2017.
In compliance with Oncotarget's withdrawal policy, the paper was withdrawn in its entirety. It will not appear in Oncotarget internal or any external indexes or archives.

Research Papers:

Association between ADIPOQ rs2241766 polymorphism and risk of diabetic nephropathy

Hanyu Zhu, Dong Zhang, Wenjia Geng, Ying Zheng, Jie Wu, Zheyi Dong, Weiguang Zhang, Fenglin Xiao, Moyan Liu, Zuoxiang Li, Shuwei Duan, Guangyan Cai and Xiangmei Chen _

Hanyu Zhu1,*, Dong Zhang1,*, Wenjia Geng1, Ying Zheng1, Jie Wu1, Zheyi Dong1, Weiguang Zhang1, Fenglin Xiao1, Moyan Liu1, Zuoxiang Li1, Shuwei Duan1, Guangyan Cai1 and Xiangmei Chen1

1Department of Nephrology, Chinese PLA General Hospital, Chinese PLA Institute of Nephrology, State Key Laboratory of Kidney Diseases, National Clinical Research Center of Kidney Diseases, Beijing Key Laboratory of Kidney Disease, Beijing, China

*These authors contributed equally to this work

Correspondence to:

Xiangmei Chen, email: [email protected]

Keywords: ADIPOQ; polymorphism; diabetic nephropathy; susceptibility

Received: June 30, 2016 Accepted: September 21, 2016 Published: August 03, 2017

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 19834

Publication Alerts

Withdrawal Notice

Research Papers:

Association between ADIPOQ rs2241766 polymorphism and risk of diabetic nephropathy